[1] 陈哲,郭成山.自身免疫耐受失调及其在免疫性血小板减少症发病机制中的研究进展[J].国际免疫学杂志,2020,43(2):196-200. [2] 秦伟,李四强.自身免疫性疾病介导的血小板减少机制研究进展[J]. 中国基层医药,2019,26(23):2941-2944. [3] NEWLAND A,LEE E J,MCDONALD V,et al.Fostamatinib for persistent/chronic adult immune thrombocytopenia[J]. Immunotherapy,2018,10(1):9-25. [4] 中华医学会血液学分会血栓与止血学组. 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J]. 中华血液学杂志,2020,41(8):617-623. [5] SACHS U J.Diagnosing immune thrombocytopenia[J]. Hamostaseologie,2019,39(3):250-258. [6] KUWANA M,OKAZAKI Y,IKEDA Y.Detection of circulating B cells producing anti-GPIb autoantibodies in patients with immune thrombocytopenia[J]. PLoS One,2014,9(1):e86943. [7] 刘静,洪永桃,夏艳辉,等. 系统性红斑狼疮伴血小板减少机制及治疗[J].中华风湿病学杂志,2015,19(8):560-563. [8] 李森,蓝夏璐,蔡华聪,等. 伴血小板减少原发性抗磷脂综合征的临床特征及相关因素分析[J]. 中华血液学杂志,2021,42(1):33-38. [9] 杨慕然,周泽平.免疫性疾病继发性ITP临床特点及治疗研究进展[J]. 中国免疫学杂志,2021,37(3):361-366. [10] FONSECA S,LACERDA C,GANHÃO I,et al. Thrombocytopaenia and thyroiditis:coincidence?[J]. BMJ Case Rep,2019,12(7):e228411. [11] 郑静娴,李晓辉,孙洪强. 儿童免疫性血小板减少症的临床观察及抗核抗体在其中作用的研究[J].临床输血与检验,2021,23(2):231-235. [12] PEREIRA K N,DE CARVALHO J A M,PANIZ C,et al. Diagnostic characteristics of immature platelet fraction for the assessment of immune thrombocytopenia[J]. Thromb Res,2021,202:125-127. [13] JEON K,KIM M,LEE J,et al.Immature platelet fraction:a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery[J]. Medicine,2020,99(7):e19096. [14] LIU Y,CHEN S J,SUN Y C,et al.Clinical characteristics of immune thrombocytopenia associated with autoimmune disease:a retrospective study[J]. Medicine,2016,95(50):e5565. [15] 何娅,田梅. 常见自身抗体在自身免疫性疾病中的研究进展[J]. 海南医学,2020,31(3):360-364. [16] 高健,徐刚. 儿童免疫性血小板减少症的治疗进展[J]. 国际儿科学杂志,2020,47(11):787-791. |